| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/24/2003 | WO2001080900A3 Enhanced stabilised plasmid-lipid particle-mediated transfection using endosomal membrane |
| 04/24/2003 | US20030078672 Polysaccharide sponges for cell culture and transplantation |
| 04/24/2003 | US20030078671 Prevention of myocardial infarction induced ventricular expansion and remodeling |
| 04/24/2003 | US20030078629 System for preventing Sudden Cardiac Death by nerve sprouting from right stellate ganglion |
| 04/24/2003 | US20030078545 System for administering a drug delivery device |
| 04/24/2003 | US20030078541 Device for injection of antiparasitic agents in pets |
| 04/24/2003 | US20030078442 Crystalline base of citalopram |
| 04/24/2003 | US20030078371 Glycopeptide for use in the prevention and treatment of bacterial infections |
| 04/24/2003 | US20030078339 Degradable cross-linking agents and cross-linked network polymers formed therewith |
| 04/24/2003 | US20030078302 As carriers for delivering active agents such as peptides, drugs by administration, such as oral, subcutaneous, sublingual, and intranasal administration |
| 04/24/2003 | US20030078285 Liquid for oral administration comprising paroxetine |
| 04/24/2003 | US20030078266 Powder of 30-90% a water-soluble cycloxygenase inhibitor, 5-60% of a buffer and 0-10% of other excipients |
| 04/24/2003 | US20030078257 Methods of treating tumors |
| 04/24/2003 | US20030078246 Combinations for the treatment of inflammatory disorders |
| 04/24/2003 | US20030078241 Treating effects of excessive reactive oxygen species |
| 04/24/2003 | US20030078238 Stabilization method of nano-sized emulsion using tocopheryl derivatives and external application for skin containing the same |
| 04/24/2003 | US20030078234 Applying semi-crystalline acetylglucosamine polysaccharide for treating vasoconstriction, reduction in blood flow |
| 04/24/2003 | US20030078230 Stabilizing, shaping to form particles and determining a turbidity parameter of a solution of compacted nucleic acid; drug delivery of DNA to cells, transfection |
| 04/24/2003 | US20030078229 Lyophilizable and enhanced compacted nucleic acids |
| 04/24/2003 | US20030078225 Liposomes |
| 04/24/2003 | US20030078214 Phytooestrogen selected from genistein, daidzein; for promoting health in cases of cancer, pre-menstrual syndrome, menopause or hypercholesterolaemia |
| 04/24/2003 | US20030078200 Treating a DSM-III disorder by administering to a mammal a peptide or a peptidomimetic thereof to reduce or eliminate symptoms of the DSM-III disorder |
| 04/24/2003 | US20030078196 Administering cisplatin; drug delivery; reduced dosage to prevent release into systemic circulation |
| 04/24/2003 | US20030078194 Comprises liposome core containing drugs (insulin) encapsulated within fatty acid membrane |
| 04/24/2003 | US20030077829 Lipid-based formulations |
| 04/24/2003 | US20030077823 Hair follicle stem cells for use in the treatment of nervous system disorders and cell therapy |
| 04/24/2003 | US20030077763 Polymer grafting by polysaccharide synthases |
| 04/24/2003 | US20030077682 Arginine free composition for use in treatment of thrombsis |
| 04/24/2003 | US20030077614 Nucleic acids for inhibiting hairless protein expression and methods of use thereof |
| 04/24/2003 | US20030077564 Amplification of neural cell viability in brain or spinal cord tissue after brain or spinal cord injury; obtain tissue, apply nutrient broth, monitor cell viability |
| 04/24/2003 | US20030077377 Edible powder material having excellent shelf stability |
| 04/24/2003 | US20030077335 Formulations for the prevention and treatment of insulin resistance and type 2 diabetes mellitus |
| 04/24/2003 | US20030077332 Wound healing agents; viricides |
| 04/24/2003 | US20030077330 Respiratory system disorders; remove carbon dioxide from blood |
| 04/24/2003 | US20030077329 Composition of and method for preparing stable particles in a frozen aqueous matrix |
| 04/24/2003 | US20030077327 Highly compressible ethylcellulose for tableting |
| 04/24/2003 | US20030077326 Mixture containing water insoluble polymer, plasticizer and drug; film forming |
| 04/24/2003 | US20030077325 Mixture of drug and hydrophilic polymer; water solubility |
| 04/24/2003 | US20030077324 Control release formulation containing a hydrophobic material as the sustained release agent |
| 04/24/2003 | US20030077323 Amoxicillin - clarithromycin antibiotic composition |
| 04/24/2003 | US20030077322 Solid dispersion system of pranlukast with improved dissolution and method for preparing the same |
| 04/24/2003 | US20030077321 Complex containing tannin; solid dosage form; sustained release |
| 04/24/2003 | US20030077320 Hydrocodone therapy |
| 04/24/2003 | US20030077319 Double-headed, closed-mouth cough suppressant and cold relief device |
| 04/24/2003 | US20030077317 Drug delivery; adhesion to mucous membranes; biopolymer |
| 04/24/2003 | US20030077316 Patch containing drug; flexible backing; pressure sensitive adhesive |
| 04/24/2003 | US20030077315 Method and dosage form for dispensing a bioactive substance |
| 04/24/2003 | US20030077313 Anti-stress composition intended for incorporation mainly in nutritional vehicles |
| 04/24/2003 | US20030077308 Topical compositions for veterinary uses |
| 04/24/2003 | US20030077307 Film-forming compositions for protecting skin from body fluids and articles made therefrom |
| 04/24/2003 | US20030077306 Emulsions as solid dosage forms for oral administration |
| 04/24/2003 | US20030077305 Administering to a mammal a formualtion comprising cationic lipids/DNA complex, allowing the complex to associate with angiogenic endothelial cells of an angiogenic blood vessel for a time such that the complex enters the target cells |
| 04/24/2003 | US20030077304 Gel composition for the topical treatment of poison ivy and other forms of contact dermatitis |
| 04/24/2003 | US20030077303 Consists of naproxen, a butyl spacer and a nitrogen oxide (NO)-releasing nitrate group, linked together into a single molecule; useful as antiinflammatory agent and an analgesic |
| 04/24/2003 | US20030077302 An ophthalmic formulation for glaucoma treatment in the form of a suspension gel containing the free acid of diclofenamide, preservatives, gel forming agent and agents to adjust the pH |
| 04/24/2003 | US20030077301 Topically administering to a localized region affected by the inflammatory dermatosis on a patient skin a formulation containing a active agent,and a permeation enhancing base to enhance the flux of active agent through skin without damage |
| 04/24/2003 | US20030077300 Pharmaceutical drug delivery applicator for the intranasal adminstration of narcotic drugs (controlled substances) such as morphine and derivatives for acute pain management through pharmaceutical intervention |
| 04/24/2003 | US20030077297 Pharmaceutical formulations and systems for improved absorption and multistage release of active agents |
| 04/24/2003 | US20030077296 Gels for topical application to female genitalia include propylene glycol a humectant solvent; aloe barbadensis leaf juice as skin-conditioner, hydroxyethylcellulose binder, menthol an analgesic stimulant, methylpraban, ginseng root |
| 04/24/2003 | US20030077260 Hybrid matrix implants and explants |
| 04/24/2003 | US20030077253 Implantable or insertable therapeutic agent delivery device |
| 04/24/2003 | US20030077245 A polyalkylene oxide-ethylene oxide block copolymer as antigrowth agents |
| 04/24/2003 | US20030077244 A biocompatible crosslinking polymer comprising acrylamide and methylene bis-acrylamide; medical procedure involves injection of polyacrylamide gel under the mucous membrane |
| 04/24/2003 | US20030077242 Methods for forming regional tissue adherent barriers and drug delivery systems |
| 04/24/2003 | US20030077240 Use of high-purity phenylsilsesquioxane liquids for the preparation of cosmetic and pharmaceutical compositions |
| 04/24/2003 | US20030077230 Container equipped with a metering valve and containing a pressurized formulation of beta-agonist drug, a fluoroalkane propellant and > 5% of a solvent |
| 04/24/2003 | US20030077229 Aqueous polar solvent, active compound, and flavoring agents; propellant-free |
| 04/24/2003 | US20030077228 Polar solvent 30-99.69%, active compound 0.001-60%, and f lavoring agent 0.1-10%; propellant free |
| 04/24/2003 | US20030077227 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
| 04/24/2003 | US20030075817 Process for producing microsphere |
| 04/24/2003 | US20030075470 Transdermal/transmucosal patch packaging |
| 04/24/2003 | US20030075172 Method and apparatus for dispensing inhalator medicament |
| 04/24/2003 | US20030075106 Fluid ejection cartridge and system for dispensing a bioactive substance |
| 04/24/2003 | CA2781766A1 Method of stabilizing reduced coenzyme q10 |
| 04/24/2003 | CA2727642A1 Synthesis of cyclosporin analogs |
| 04/24/2003 | CA2466082A1 Anti-microbial composition comprising a metal ion chelating agent |
| 04/24/2003 | CA2463991A1 Therapeutic composition and use |
| 04/24/2003 | CA2463729A1 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors |
| 04/24/2003 | CA2463711A1 Compositions and methods for delivering antibacterial, antifungal and antiviral ointments to the oral, nasal or vaginal cavity |
| 04/24/2003 | CA2463686A1 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them |
| 04/24/2003 | CA2463685A1 Novel .beta.-phenyl-.alpha.-oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds |
| 04/24/2003 | CA2463674A1 Controlled release capsules for providing both pulsed burst and controlled release of drugs to the rumen of ruminant animals over an extended time period |
| 04/24/2003 | CA2463655A1 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (tfpi) |
| 04/24/2003 | CA2463574A1 Medical device for delivering patches |
| 04/24/2003 | CA2463459A1 Novel use of pulmonary surfactant |
| 04/24/2003 | CA2463435A1 Pharmaceutical combinations comprising salmeterol and fluticasone proprionate for the treatment of asthma |
| 04/24/2003 | CA2462639A1 Kahalalide compounds for use in cancer therapy |
| 04/24/2003 | CA2462219A1 Pharmaceutical formulation comprising (r) -bicalutamide |
| 04/24/2003 | CA2461740A1 Synthesis of cyclosporin analogs |
| 04/24/2003 | CA2461556A1 Compositions and methods for delivery of microparticles of poorly water soluble drugs and methods of treatment |
| 04/24/2003 | CA2461550A1 Stabilized compositions of aqueous reduced coenzyme q solution |
| 04/24/2003 | CA2461168A1 Pharmaceutical formulations for the controlled release of 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl) quinazoline |
| 04/24/2003 | CA2460738A1 Laminated patient infusion device |
| 04/24/2003 | CA2460685A1 Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 04/24/2003 | CA2460574A1 Enteric coated tablets comprising mycophenolic acid or mycophenolate salt |
| 04/24/2003 | CA2460209A1 A method for preparing liposome formulations with a predefined release profile |
| 04/24/2003 | CA2460132A1 Use of a copolymer to produce a galenic form containing a peptide or a protein as active agent |
| 04/24/2003 | CA2451953A1 Methods for hermetically sealing microchip reservoir devices |
| 04/23/2003 | EP1304384A1 Biodegradable articles obtained from enzymatically synthesized amylose |
| 04/23/2003 | EP1304346A2 Conjugate of polyethylene glycol and chitosan |